A Randomized, Placebo-Controlled, Double-Blind Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeated Doses of Mirogabalin in Healthy Asian Volunteers-Reference-Cited by-同舟云学术

A Randomized, Placebo-Controlled, Double-Blind Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeated Doses of Mirogabalin in Healthy Asian Volunteers

Published:2018-04-17 Issue:6 Volume:7 Page:661-669
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Jansen Mendel¹,Warrington Steven²,Dishy Victor³,Ohwada Shoichi⁴,Johnson Lisa¹,Brown Karen³,Ishizuka Hitoshi⁴

Affiliation:

1. Daiichi Sankyo Development Ltd; Gerrards Cross Buckinghamshire UK

2. Hammersmith Medicines Research; London UK

3. Daiichi Sankyo Pharma Development; Basking Ridge NJ USA

4. Daiichi Sankyo Co.Ltd.; Hiromachi, Shinagawa-ku Tokyo Japan

Funder

Daiichi-Sankyo

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpdd.448/fullpdf

Reference19 articles.

1. Pharmacological, pharmacokinetics and safety profiles of DS-5565, a novel α2δ ligand (P7.301);Yokoyama T;Neurology,2014

2. The increased trafficking of the calcium channel subunit α2δ-1 to presynaptic terminals in neuropathic pain is inhibited by the α2δ ligand pregabalin;Bauer;J Neurosci,2009

3. Mechanisms and management of diabetic painful distal symmetrical polyneuropathy;Tesfaye;Diabetes Care,2013

4. Identification of the α2δ-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin;Field;Proc Natl Acad Sci U S A,2006

5. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the α2δ subunit of a calcium channel;Gee;J Biol Chem,1996

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and Bioequivalence of Mirogabalin Orally Disintegrating Tablets and Conventional Tablets in Healthy Japanese Participants;Clinical Pharmacology in Drug Development;2023-06-13

2. The Clinical Application and Progress of Mirogabalin on Neuropathic Pain as a Novel Selective Gabapentinoids;Mediators of Inflammation;2023-04-28

3. Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study;Advances in Therapy;2023-02-15

4. Renal tubular transporter-mediated interactions between mirogabalin and cimetidine in rats;Xenobiotica;2023-02-01

5. Mirogabalin for Central Neuropathic Pain After Spinal Cord Injury;Neurology;2022-12-14